[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100474631":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":23,"centralContacts":28,"locations":37,"responsibleParty":51,"collaborators":11,"id":54,"slug":11,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":55,"sex":61,"minAge":62,"maxAge":63,"enrollmentInfo":64,"targetDuration":11,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":74,"overallStatus":40,"whyStopped":11,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Liege","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment by acetylsalicylic acid","EXPERIMENTAL",null,[13],"Drug: Acetylsalicylic acid",{"label":15,"type":16,"description":11,"interventionNames":11},"No treatment","NO_INTERVENTION",[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":11},"DRUG","Acetylsalicylic acid","160mg once a day",[9],[24],{"name":25,"affiliation":26,"role":27},"Laurie Henry","Centre Hospitalier Régional de la Citadelle","PRINCIPAL_INVESTIGATOR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":11,"email":33},"Julie Collée","CONTACT","+32498973386","julie.collee@uliege.be",{"name":35,"role":31,"phone":11,"phoneExt":11,"email":36},"Marie Timmermans","marie.timmermans@chuliege.be;",[38],{"facility":39,"status":40,"city":41,"state":11,"zip":11,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Centre Hospitalier Universitaire de Liège site Citadelle","RECRUITING","Liège","Belgium",{"type":44,"coordinates":45},"Point",[46,47],5.56749,50.63373,{"lat":47,"lon":46},[50],{"name":30,"role":31,"phone":11,"phoneExt":11,"email":33},{"type":27,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":26,"oldNameTitle":11,"oldOrganization":11},"Julie Collee","Doctor, specialist in Obstetrics and Reproductive Medicine","100474631",false,"NCT05460416","Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer","A Prospective Interventional Randomized Controlled Trial to Assess the Effect of Low Dose Acetylsalicylic Acid As a Preventive Treatment of Pre-eclampsia in Pregnant Women Who Underwent Frozen Embryo Transfer","TePPAFET","Inclusion Criteria:\n\n* Healthy women from \\[18 - 43\\] years-old, planned for a frozen embryo transfer, with natural and modified natural or HRT cycle\n* Who have given their informed consent\n* Who have a confirmed pregnancy at week 6 of amenorrhea.\n\nExclusion Criteria:\n\n* Women presenting one risk factor for preeclampsia: multiple pregnancy, history of preeclampsia, BMI \\> 30, lupus syndrome, preexistent proteinuria, non-treated chronic high blood pressure (\\>140\u002F90), antiphospholipid antibody syndrome, diabetes (fasting blood sugar \\>126mg\u002Fdl)\n* Contraindication to acetylsalicylic acid (at risk of active hemorrhage (like hemophilia, …); at risk of or who have a gastro-duodenal ulcer; at risk or how have a terminal renal or hepatic in-sufficiency (only if acetylsalicylic acid is given at high dose)\n* Already treated with acetylsalicylic acid\n* Treatment with anticoagulants or non-steroid anti-inflammatory drugs","FEMALE","18 Years","43 Years",{"count":65,"type":66},276,"ESTIMATED","INTERVENTIONAL",[69],"PHASE3","Title: A prospective multicentric interventional randomized controlled trial to assess the effect of low dose acetylsalicylic acid as a preventive treatment of pre-eclampsia in pregnant women who underwent frozen embryo transfer",[72,73],"Embryo Transfer","Hypertension, Pregnancy Induced",[75,76],"embryo transfer","Hypertension, Pregnancy induced","2025-02-14",{"date":79,"type":80},"2025-02-18","ACTUAL",{"date":82,"type":80},"2022-10-25",{"date":84,"type":66},"2026-06-30",{"name":5,"class":6},1]